ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Scope & Guideline

Driving excellence in vascular research for a healthier tomorrow.

Introduction

Explore the comprehensive scope of ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1079-5642
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationARTERIOSCL THROM VAS / Arterioscler. Thromb. Vasc. Biol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is dedicated to publishing high-quality research that advances the understanding of vascular biology, particularly in relation to cardiovascular diseases, thrombosis, and atherosclerosis. The journal emphasizes both basic and clinical research, fostering an interdisciplinary approach that incorporates molecular biology, genetics, and epidemiology.
  1. Vascular Biology and Pathophysiology:
    Research focused on the cellular and molecular mechanisms underlying vascular health and disease, including endothelial function, smooth muscle cell dynamics, and the role of vascular inflammation in atherogenesis.
  2. Thrombosis and Hemostasis:
    Investigations into the mechanisms of blood clot formation and resolution, including studies on platelets, coagulation factors, and the impact of various pathological conditions on thrombotic processes.
  3. Atherosclerosis Mechanisms:
    Studies elucidating the pathophysiology of atherosclerosis, including lipid metabolism, inflammatory processes, and the role of immune cells in plaque formation and stability.
  4. Genetic and Environmental Risk Factors:
    Exploration of genetic determinants and environmental influences on cardiovascular disease risk, with a focus on identifying novel biomarkers and therapeutic targets.
  5. Innovative Therapeutic Strategies:
    Research on new therapeutic approaches for cardiovascular diseases, including drug development, gene therapy, and the use of advanced biomaterials for vascular repair.
  6. Translational Research:
    Bridging basic science with clinical applications, aiming to translate findings from laboratory research into effective treatments and interventions for cardiovascular diseases.
The journal has shown a dynamic evolution in its focus areas, with emerging themes reflecting the latest advancements in vascular biology, technology, and clinical practice. These trends indicate a shift towards more integrated and innovative research methodologies.
  1. Precision Medicine Approaches:
    An increasing number of studies focus on personalized medicine, utilizing genetic and molecular profiling to tailor interventions for cardiovascular diseases, reflecting a broader trend in healthcare.
  2. Role of the Microbiome:
    Research exploring the influence of gut microbiota on cardiovascular health is gaining traction, with studies linking microbial metabolites to vascular inflammation and atherosclerosis.
  3. Immunometabolism in Cardiovascular Disease:
    The intersection of immune responses and metabolic processes in vascular disease is emerging as a critical area of research, highlighting the role of inflammation in atherosclerosis and thrombosis.
  4. Innovative Imaging and Biomarker Technologies:
    Advancements in imaging techniques and biomarker discovery are increasingly featured, enabling more precise monitoring of vascular health and disease progression.
  5. Novel Therapeutic Modalities:
    There is a rising interest in novel therapeutic strategies, including the use of nanoparticles, CRISPR technology, and RNA-based therapies, aimed at addressing vascular disease at a molecular level.
  6. Cellular Plasticity and Regenerative Medicine:
    Research on the plasticity of vascular cells and their potential for regeneration and repair is becoming more prominent, particularly in the context of stem cell therapies and tissue engineering.

Declining or Waning

While the journal continues to thrive in many areas, some themes have seen a decline in focus over recent years. These waning scopes may reflect shifts in research priorities or advancements in understanding that have led to saturation in particular topics.
  1. Traditional Risk Factor Studies:
    Research focusing solely on conventional cardiovascular risk factors (e.g., hypertension, cholesterol levels) has decreased as the field moves towards more complex, multifactorial models of disease.
  2. Basic Animal Models:
    There is a noticeable reduction in studies utilizing traditional animal models without incorporating modern techniques such as genetic manipulation or advanced imaging, as researchers seek more relevant and translationally applicable models.
  3. Single-Factor Interventions:
    Research that examines the effects of single interventions on vascular health, without considering the multifaceted interactions present in human health, is becoming less prevalent as the complexity of cardiovascular disease is better appreciated.
  4. Epidemiological Studies with Limited Scope:
    Epidemiological studies that focus narrowly on specific populations without integrating broader systemic factors are declining, as there is a push for more comprehensive approaches to understanding cardiovascular health across diverse populations.

Similar Journals

JOURNAL OF VASCULAR RESEARCH

Advancing vascular knowledge since 1964.
Publisher: KARGERISSN: 1018-1172Frequency: 6 issues/year

Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.

Annals of Vascular Diseases

Advancing Vascular Research for a Healthier Tomorrow
Publisher: ANNALS VASCULAR DISEASES EDITORIAL OFFICEISSN: 1881-641XFrequency: 4 issues/year

Annals of Vascular Diseases is a leading international journal dedicated to the comprehensive exploration of vascular pathology, aimed at advancing knowledge in the field through innovative research and insightful reviews. Published by the ANNALS VASCULAR DISEASES EDITORIAL OFFICE and available in both print (ISSN: 1881-641X) and electronic format (E-ISSN: 1881-6428), this journal has embraced Open Access since 2017, facilitating wider dissemination and accessibility of vital research findings. With its focus on clinical and experimental studies relating to vascular diseases, the journal serves as a crucial platform for researchers, medical professionals, and students who seek to stay at the forefront of clinical advancements. By fostering collaboration and sharing knowledge, Annals of Vascular Diseases plays a significant role in shaping the future of vascular research and treatment strategies worldwide.

MICROVASCULAR RESEARCH

Charting New Territories in Microvascular Research
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0026-2862Frequency: 6 issues/year

Microvascular Research is a prominent journal dedicated to advancing the understanding of microvascular biology and its implications in various health and disease contexts. Published by Academic Press Inc elsevier Science, this journal holds a significant place in the academic community with an impact factor reflecting its high citation frequency and relevance within its fields. With a Q2 ranking in both Biochemistry and Cardiology and Cardiovascular Medicine, as well as a Q3 ranking in Cell Biology, it provides an essential platform for researchers and professionals to publish and access groundbreaking studies. Established in 1968 and running through to 2025, Microvascular Research covers a broad scope, focusing on various topics related to microvessels and their functions, emphasizing the importance of these structures in health and pathology. Although the journal does not offer open access, it remains a vital resource for those seeking to deepen their understanding of microvascular dynamics, making it an essential addition to the libraries of researchers, clinicians, and students alike.

JOURNAL OF CARDIOVASCULAR SURGERY

Fostering excellence in cardiac surgical techniques.
Publisher: EDIZIONI MINERVA MEDICAISSN: 0021-9509Frequency: 6 issues/year

JOURNAL OF CARDIOVASCULAR SURGERY, published by EDIZIONI MINERVA MEDICA, stands as a pivotal resource in the field of cardiovascular medicine and surgical practices. With a rich history dating back to 1960 and ongoing contributions scheduled until 2024, this esteemed journal provides a platform for the dissemination of innovative research in cardiology and surgical techniques. Registered under ISSN 0021-9509 and E-ISSN 1827-191X, it holds a commendable standing reflected in its Scopus rankings, placing it in the second quartile for both cardiology and cardiovascular medicine, as well as surgery. Despite not currently offering Open Access, the journal remains a vital source for practitioners and researchers alike, facilitating a deeper understanding of advancing methodologies and clinical practices in cardiovascular surgery. The journal is headquartered in Turin, Italy, and is committed to nurturing academic excellence within the community, making it an essential read for professionals, researchers, and students striving to enhance their knowledge and expertise in this critical field.

GENESIS

Connecting Disciplines, Inspiring Discoveries
Publisher: WILEYISSN: 1526-954XFrequency: 12 issues/year

GENESIS is a renowned journal dedicated to advancing the fields of Cell Biology, Endocrinology, Genetics, and Miscellaneous Medicine, published by WILEY. With an ISSN of 1526-954X and an E-ISSN of 1526-968X, this journal has established a significant presence in academic publishing since its inception in 2000. Positioned within the Q3 category for Cell Biology and Q2 categories for Endocrinology, Genetics, and Medicine in the 2023 rankings, GENESIS offers an interdisciplinary platform that fosters pioneering research and innovation. Additionally, the journal provides options for Open Access, ensuring that vital discoveries are accessible to a broader audience. Researchers, professionals, and students alike will find valuable insights and cutting-edge studies within its pages, making GENESIS a crucial resource for anyone invested in the biological sciences.

Acta Angiologica

Fostering Collaboration in Vascular Medicine
Publisher: VIA MEDICAISSN: 1234-950XFrequency: 4 issues/year

Acta Angiologica, published by VIA MEDICA, is an Open Access journal dedicated to the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1995, this esteemed journal has provided a vital platform for the dissemination of cutting-edge research and innovative medical practices, especially pertinent to vascular health. Being indexed in Scopus, it holds a rank of #352 out of 387 in its category for 2023, positioning it in the 9th percentile among contemporaneous journals. The journal's commitment to scholarly excellence and accessibility is underscored by its embrace of open access publishing, allowing researchers, professionals, and students to engage with vital advancements in the field without financial barriers. With a converged timeline from 2005 to 2024, Acta Angiologica continues to play a crucial role in bridging gaps in cardiovascular knowledge, fostering collaboration across disciplines, and advancing the implementation of preventative and therapeutic strategies in vascular medicine. Located in Gdansk, Poland, the journal is poised to make significant contributions to the cardiovascular research landscape.

Vascular Specialist International

Bridging knowledge gaps in vascular healthcare across borders.
Publisher: KOREAN SOC VASCULAR SURGERYISSN: 2288-7970Frequency: 4 issues/year

Vascular Specialist International, published by the Korean Society of Vascular Surgery, serves as a pivotal platform in the field of vascular surgery and cardiovascular medicine. With an Open Access policy established since 2014, the journal encourages a broader dissemination of research findings to an international audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal, ISSN 2288-7970, is headquartered in South Korea and spans a significant publication back to its inception, focusing on advancing clinical practice and research in vascular health. In the 2023 rankings, it is positioned in quartile Q4 for Cardiology and Cardiovascular Medicine and Q3 for Surgery, reflecting its growing impact within the scientific community. Furthermore, it holds commendable Scopus rankings in both categories, indicating its relevance and contributions to the field. With a mission to enhance vascular surgery practices and improve patient outcomes worldwide, Vascular Specialist International stands as an essential resource for those dedicated to advancing the science and art of vascular healthcare.

CIRCULATION

Driving Discoveries in Cardiovascular Health Since 1950.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

CIRCULATION RESEARCH

Leading the way in cardiovascular research since 1953.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7330Frequency: 24 issues/year

CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.

Vasa-European Journal of Vascular Medicine

Connecting Researchers and Clinicians in Vascular Excellence
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 0301-1526Frequency: 6 issues/year

Vasa - European Journal of Vascular Medicine is a leading peer-reviewed journal dedicated to advancing the field of vascular medicine, published by HOGREFE AG in Switzerland. With a proud history dating back to 1972, this journal serves as a critical platform for researchers, clinicians, and healthcare professionals committed to enhancing knowledge and practice related to cardiovascular health and vascular disorders. Holding a notable Q2 ranking in the cardiology and cardiovascular medicine category, Vasa’s scholarly contributions reflect high-quality research and innovative insights that drive clinical applications. The journal provides essential access to original articles, reviews, and case studies, fostering a vibrant exchange of ideas within the vascular medicine community. Its Scopus rank of #159 out of 387 further underscores its impact, placing it confidently in the 59th percentile among its peers. Vasa is synonymous with rigorous academic standards and relevance, making it an invaluable resource for anyone seeking to stay at the forefront of vascular research and its clinical implications.